Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.028 | 0.6 |
mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.026 | 0.6 |
mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.6 |
mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |